Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 2307837 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of hla mismatched t cell-depleted marrow for severe combined immunodeficiency. | |||||||
| 2307837 | HLA (HLA) | severe combined immunodeficiency | NA | NA | NA | unclassified | |
| both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of hla mismatched t cell-depleted marrow for severe combined immunodeficiency. | |||||||
| 2308996 | HLA MISMATCHED (HLA-MISMATCHED) | transplantation | NA | NA | NA | unclassified | |
| efficacy of t cell depletion of surgically resected cadaveric marrows by monoclonal antibodies: considerations in hla-mismatched marrow transplantation. | |||||||
| 2308996 | HLA MISMATCHED (HLA-MISMATCHED) | cadaver | NA | NA | NA | unclassified | |
| efficacy of t cell depletion of surgically resected cadaveric marrows by monoclonal antibodies: considerations in hla-mismatched marrow transplantation. | |||||||
| 2308996 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| these marrow have been cryopreserved as a bank of characterized donor marrow for use in hla minimally matched or unmatched marrow transplantation. | |||||||
| 2308996 | HLA MATCHED (HLA-MATCHED) | bone marrow transplantation | NA | NA | NA | unclassified | |
| the potential therapeutic benefits of allogeneic bone marrow transplantation (bmt) remain generally unavailable to patients who have diseases amenable to treatment by allogeneic bmt, but who lack an identifiable hla-matched marrow donor. | |||||||
| 2308996 | HLA MATCHED (HLA-MATCHED) | diseases | NA | NA | NA | unclassified | |
| the potential therapeutic benefits of allogeneic bone marrow transplantation (bmt) remain generally unavailable to patients who have diseases amenable to treatment by allogeneic bmt, but who lack an identifiable hla-matched marrow donor. | |||||||
| 2308996 | HLA MATCHED (HLA-MATCHED) | graft versus host disease | NA | NA | NA | unclassified | |
| if graft versus host disease and graft rejection can be controlled, then the possibility of expanding allogeneic bmt to minimally hla-matched or fully mismatched combinations exists and a "universal" donor marrow bank might be established. | |||||||
| 2311644 | MHC (MHC) | transplantation | NA | NA | NA | unclassified | |
| molecular analysis of hla class ii polymorphism represents a crucial parameter for hla matching in transplantation immunology, for the study of hla-disease association and for the understanding of major histocompatibility complex (mhc)-restricted antigen presentation. | |||||||
| 2311644 | HLA-CLASS II (HLA CLASS II) | transplantation | NA | NA | NA | unclassified | |
| molecular analysis of hla class ii polymorphism represents a crucial parameter for hla matching in transplantation immunology, for the study of hla-disease association and for the understanding of major histocompatibility complex (mhc)-restricted antigen presentation. | |||||||
Copyright 2024